Sign In

Login

Password

Forgot Password ? Sign Up

NeuroSearch (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "NeuroSearch" in English language version.

Last modified:

Ref.Un. Ref.Website
Global rank English rank
22doi.org
2nd place
2nd place
22nih.gov
5th place
5th place
22semanticscholar.org
15th place
8th place
11hdbuzz.net
low place
low place
11omxgroup.com
low place
low place

doi.org (Global: 2nd place; English: 2nd place)

  • de Yebenes, Justo Garcia; Landwehrmeyer, Bernhard; Squitieri, Ferdinando; Reilmann, Ralf; Rosser, Anne; Barker, Roger A; Saft, Carsten; Magnet, Markus K; Sword, Alastair; Rembratt, Åsa; Tedroff, Joakim (1 December 2011). "Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial". The Lancet Neurology. 10 (12): 1049–1057. doi:10.1016/S1474-4422(11)70233-2. PMID 22071279. S2CID 39984761.
  • Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM (2008). "Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial". Lancet. 372 (9653): 1906–13. doi:10.1016/S0140-6736(08)61525-1. PMID 18950853. S2CID 30725634.

hdbuzz.net (Global: low place; English: low place)

nih.gov (Global: 5th place; English: 5th place)

pubmed.ncbi.nlm.nih.gov

  • de Yebenes, Justo Garcia; Landwehrmeyer, Bernhard; Squitieri, Ferdinando; Reilmann, Ralf; Rosser, Anne; Barker, Roger A; Saft, Carsten; Magnet, Markus K; Sword, Alastair; Rembratt, Åsa; Tedroff, Joakim (1 December 2011). "Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial". The Lancet Neurology. 10 (12): 1049–1057. doi:10.1016/S1474-4422(11)70233-2. PMID 22071279. S2CID 39984761.
  • Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM (2008). "Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial". Lancet. 372 (9653): 1906–13. doi:10.1016/S0140-6736(08)61525-1. PMID 18950853. S2CID 30725634.

omxgroup.com (Global: low place; English: low place)

newsclient.omxgroup.com

semanticscholar.org (Global: 15th place; English: 8th place)

api.semanticscholar.org

  • de Yebenes, Justo Garcia; Landwehrmeyer, Bernhard; Squitieri, Ferdinando; Reilmann, Ralf; Rosser, Anne; Barker, Roger A; Saft, Carsten; Magnet, Markus K; Sword, Alastair; Rembratt, Åsa; Tedroff, Joakim (1 December 2011). "Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial". The Lancet Neurology. 10 (12): 1049–1057. doi:10.1016/S1474-4422(11)70233-2. PMID 22071279. S2CID 39984761.
  • Astrup A, Madsbad S, Breum L, Jensen TJ, Kroustrup JP, Larsen TM (2008). "Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial". Lancet. 372 (9653): 1906–13. doi:10.1016/S0140-6736(08)61525-1. PMID 18950853. S2CID 30725634.